Stage III breast cancer represents a more advanced phase of the disease where cancer has moved beyond the breast tissue into nearby areas such as lymph nodes, the skin of the breast, or the chest wall, though it has not yet reached distant organs in the body.
What Is Stage III Breast Cancer?
Stage III breast cancer, also known as locally advanced breast cancer, is a more serious form of the disease than earlier stages. At this point, the cancer has spread beyond the breast tissue itself but has not yet traveled to distant parts of the body like the liver, lungs, or bones. This stage sits between earlier, more contained cancers and stage IV disease, which has spread to distant organs[2][5].
The defining feature of stage III breast cancer is that cancer cells have reached nearby lymph nodes or other tissues close to the breast. Lymph nodes are small, bean-shaped structures that help the body fight infection and disease. When breast cancer reaches these nodes, it means the disease has begun to travel through the body’s lymphatic system, which is a network of vessels and nodes throughout the body[10].
Stage III is divided into three subcategories—3A, 3B, and 3C—based on the size of the tumor, how many lymph nodes contain cancer, and whether the cancer has reached the skin or chest wall. Each subcategory carries different characteristics and treatment considerations, but all represent locally advanced disease that requires comprehensive treatment[2][6].
Understanding Stage III Subcategories
Stage 3A breast cancer can mean several things. In some cases, there may be no visible cancer in the breast itself, or the tumor may be any size, but cancer has spread to four to nine lymph nodes under the arm or near the breastbone. Another scenario involves a tumor larger than five centimeters that has spread to one to three lymph nodes under the arm or near the breastbone. These different patterns all fall under the 3A classification because they represent similar levels of disease spread[2][10].
Stage 3B indicates that the cancer has spread to the skin of the breast or to the chest wall, which includes the structures surrounding and protecting the lungs, such as ribs, muscles, and connective tissues. The cancer may have caused the skin to break down, creating an ulcer, or it may have caused swelling. Cancer may have also spread to up to nine lymph nodes in the armpit or near the breastbone. A specific type called inflammatory breast cancer is often classified as stage 3B. This type causes the breast to become red and swollen, and the skin may look dimpled like an orange peel[2][10].
Stage 3C represents the most advanced form of stage III disease. The cancer may be any size or there may be no cancer visible in the breast at all, but it has spread extensively to lymph nodes. This could mean cancer in ten or more lymph nodes in the armpit, lymph nodes above or below the collarbone, or lymph nodes both in the armpit and near the breastbone. The cancer may have also grown into the chest wall or skin of the breast[2][10].
Symptoms of Stage III Breast Cancer
The symptoms of locally advanced breast cancer can be more noticeable than those of earlier stages. Some people may find a lump in the breast that feels attached to the chest wall and doesn’t move freely when touched. This fixed quality occurs because the cancer has grown into the surrounding tissues[5][13].
Skin changes are common in stage III disease. The skin may become thickened and develop a dimpled appearance that resembles the texture of an orange peel. In medical terms, this is called peau d’orange, which is French for “orange peel.” The skin may also break down and form an ulcer, which is an open sore. Some people notice that their entire breast becomes large, red, and swollen, especially in cases of inflammatory breast cancer[5][13].
A large lump in the armpit that doesn’t move freely from the chest wall can indicate that cancer has spread to the lymph nodes in that area. Some people may also notice a lump at the base of the neck, which suggests cancer has reached lymph nodes above the collarbone. These physical signs often prompt people to seek medical attention, leading to diagnosis[5][13].
How Stage III Breast Cancer Is Diagnosed
Doctors use a system called TNM staging to classify breast cancer. The letters stand for Tumor, Node, and Metastasis. The T describes the size of the tumor or whether it has grown into nearby structures. The N describes whether cancer has spread to nearby lymph nodes and how many are affected. The M indicates whether cancer has spread to distant parts of the body. Each letter is assigned a number, and these numbers together determine the overall stage[2][10].
Staging for breast cancer involves many factors and can be quite complex. Doctors consider not only the size and spread of the tumor but also characteristics of the cancer cells themselves. They look at whether the cancer cells have receptors for hormones like estrogen or progesterone, and whether they have high levels of a protein called HER2. These biological features help doctors understand how the cancer might behave and which treatments might work best[2][10].
The grade of the cancer is another important factor. Grade refers to how abnormal the cancer cells look under a microscope and how quickly they appear to be growing. Higher-grade cancers tend to grow and spread more quickly than lower-grade ones. All of these pieces of information come together to give a complete picture of the disease[2][10].
Treatment Approaches for Stage III Breast Cancer
Treatment for stage III breast cancer typically involves multiple approaches working together. Because the cancer has spread beyond the breast itself, treatment aims to eliminate cancer cells not only in the breast but also in nearby areas and throughout the body. The specific treatment plan depends on many factors, including the exact subcategory of stage III, the characteristics of the cancer cells, whether someone has gone through menopause, and other health conditions they may have[2][10].
Many people with stage III breast cancer receive chemotherapy before surgery. This approach, called neoadjuvant chemotherapy, uses drugs to kill cancer cells throughout the body. The goal is to shrink the tumor before surgery, making it easier to remove and potentially allowing for less extensive surgery. Chemotherapy given before surgery can also help doctors see how well the cancer responds to treatment, which provides valuable information about the disease[2][10][11].
For cancers that have receptors for hormones, hormone therapy may be given before surgery instead of or in addition to chemotherapy. This type of treatment blocks the hormones that help the cancer grow. If cancer cells have high levels of HER2 protein, doctors may prescribe targeted therapy drugs that specifically attack cells with this protein. These targeted drugs are often given along with chemotherapy[2][10][11].
Surgery is an essential part of treatment for stage III breast cancer. The type of surgery depends on the size and location of the cancer and the response to any treatment given beforehand. A lumpectomy removes the tumor and some surrounding tissue while preserving most of the breast. A mastectomy removes the entire breast. The surgeon will also remove lymph nodes from the armpit to check for cancer spread. After surgery, many people choose to have breast reconstruction, which uses surgical techniques to rebuild the shape of the breast[3][8][11].
Radiation therapy uses high-energy rays to kill cancer cells. It is commonly recommended after surgery for stage III breast cancer. Radiation targets the area where the tumor was located and may also treat nearby lymph node areas. This helps destroy any cancer cells that might remain after surgery, reducing the risk that the cancer will come back in that area[2][10][11].
After surgery and radiation, additional drug treatments may be given. This could include more chemotherapy, hormone therapy for several years, or targeted therapy. These treatments work to eliminate any remaining cancer cells in the body and lower the risk of the cancer returning. The specific drugs and duration of treatment are tailored to each person’s situation[3][8][11].
Special Treatment Considerations
Treatment decisions for stage III breast cancer depend heavily on the biological characteristics of the cancer cells. Cancers that are hormone receptor-positive have receptors on their surface that bind to estrogen or progesterone. These hormones can fuel the cancer’s growth. For these cancers, hormone therapy is an important part of treatment. Drugs like tamoxifen work in all women with hormone-positive cancers. Other drugs called aromatase inhibitors, which include medications like anastrozole, exemestane, and letrozole, work specifically in women who have gone through menopause. Some women who haven’t reached menopause may be offered treatments that stop their ovaries from producing hormones[11].
About one in five breast cancers are HER2-positive, meaning they have high levels of the HER2 protein. These cancers tend to grow more quickly than HER2-negative cancers. Fortunately, several targeted drugs work specifically against HER2-positive cancers. These include trastuzumab, pertuzumab, ado-trastuzumab emtansine, fam-trastuzumab deruxtecan, lapatinib, neratinib, margetuximab, and tucatinib. These drugs can be highly effective when used along with chemotherapy. They make chemotherapy work better and help prevent the cancer from growing and spreading[11].
Some cancers are negative for hormone receptors, HER2, and another marker called Ki-67. While these cancers, sometimes called triple-negative, can be more challenging to treat because they don’t respond to hormone therapy or HER2-targeted drugs, chemotherapy remains an effective treatment. Researchers continue to develop new treatments for these cancers, including immunotherapy drugs that help the body’s immune system fight the cancer[11].
Understanding Pathophysiology
In stage III breast cancer, the normal orderly process of cell growth and division has broken down. Cancer cells in the breast have accumulated genetic changes that allow them to multiply uncontrollably. These cells don’t respond to the normal signals that tell cells when to stop growing or when to die. As the cancer cells continue to multiply, they form a mass or tumor in the breast[6].
The cancer cells in stage III disease have gained the ability to invade surrounding tissues. Normal breast cells stay where they belong, but cancer cells can break through the boundaries that separate different types of tissue. They can grow into the skin above the breast or into the chest wall below. This invasive quality is what distinguishes cancer from benign tumors, which may grow large but don’t invade other tissues[5][6].
Perhaps most significantly, stage III cancer cells have begun to spread through the lymphatic system. The breast and surrounding area contain many lymphatic vessels, which are small tubes that carry lymph fluid. Cancer cells can break away from the main tumor and travel through these vessels to nearby lymph nodes. Once in the lymph nodes, the cancer cells can continue to grow, forming deposits of cancer in the nodes. This process represents a critical step in cancer progression because the lymphatic system connects to the bloodstream, potentially allowing cancer cells to travel to distant parts of the body[2][5].
The cancer cells in stage III disease have typically accumulated multiple genetic changes that drive their abnormal behavior. These changes might involve genes that normally promote cell growth becoming overactive, or genes that normally suppress tumor formation becoming inactive. The cancer cells may also produce factors that help them survive and grow, such as substances that promote the formation of new blood vessels to supply the tumor with nutrients and oxygen[6].
Clinical Trials and Research
People with stage III breast cancer may have the opportunity to participate in clinical trials, which are research studies that test new treatments. Clinical trials help doctors find better ways to treat breast cancer. Some trials test new drugs or combinations of existing drugs. Others explore new approaches to surgery or radiation therapy. Participating in a clinical trial gives people access to cutting-edge treatments that aren’t yet widely available[3][8].
Doctors conducting clinical trials follow strict protocols to ensure participant safety. Before joining a trial, people receive detailed information about what the study involves, including potential benefits and risks. They can choose to participate or not, and they can leave the study at any time. Clinical trials have led to many of the treatment advances that have improved outcomes for breast cancer over the years[3][8].
